Zhao Zhiquan, chairman and general manager of the group company, started with a net asset of 6,543.8+0.9 million yuan and a loan of 20,000 yuan, led cadres and employees to struggle hard, forged the enterprise spirit of "not afraid of difficulties, facing difficulties and overcoming difficulties", and always adhered to the business purposes of "benefiting society and creating a better life" and "relying on employees to run enterprises and run enterprises well for employees", and built a harmonious enterprise with tenacious struggle and unity.
The company has strong core competitiveness in science and technology, and is recognized as a "national key high-tech enterprise" by the Ministry of Science and Technology, with "National Enterprise Technology Center" and "Postdoctoral Research Center". Together with East China University of Science and Technology, we have established Luhuasheng Institute of Biotechnology, Institute of Supercritical Fluid Technology and Institute of Natural Medicine with Shandong University, and established perennial scientific research cooperation relations with 36 universities and scientific research institutions across the country. 1999, lunan pharmaceutical group ranks second among 292 national enterprise technology centers. Mosapride citrate and milrinone developed by the group won the second prize of national scientific and technological progress.
Lunan Pharmaceutical Group, in its prime of life and determined to globalize, has become a leading domestic and world-class pharmaceutical research and production base, and is striding forward in the direction of an international group company!